BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17163876)

  • 1. Introduction of anti-HBc testing of blood donors in Germany.
    Zeiler T; Karger R; Slonka J; Ketschmer V; Radsak K
    Transfus Med; 2006 Dec; 16(6):441-3. PubMed ID: 17163876
    [No Abstract]   [Full Text] [Related]  

  • 2. [The use of a test for anti-HBc for prevention of post-transfusion hepatitis B].
    Somova AV; Margolina AN; Golosova TV; Fisenko EP; Tsibinogin VV; Loseva VIa
    Vopr Virusol; 1989; 34(6):749-52. PubMed ID: 2633470
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of transmission of hepatitis B, hepatitis C and human immunodeficiency virus infections through blood transfusion by anti-HBc testing.
    Busch MP
    Vox Sang; 1998; 74 Suppl 2():147-54. PubMed ID: 9704438
    [No Abstract]   [Full Text] [Related]  

  • 4. High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply.
    Zheng X; Ye X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
    Transfusion; 2015 Apr; 55(4):890-7. PubMed ID: 25363504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Insufficient agreement and reproducibility of 6 different enzyme immunoassays for anti-HBc--preliminary results of a study by the West German blood bank].
    Caspari G; Beyer J; Elbert G; Koerner K; Muss P; Schunter F; Uy A; Gerlich W; Schmitt H
    Beitr Infusionsther; 1988; 21():182-6. PubMed ID: 2462973
    [No Abstract]   [Full Text] [Related]  

  • 6. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion.
    Asim M; Ali R; Khan LA; Husain SA; Singla R; Kar P
    Indian J Med Res; 2010 Sep; 132():312-7. PubMed ID: 20847378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-HBc in blood donors.
    Moore C; Barbara J; Hewitt PE
    Vox Sang; 1998; 74(3):209. PubMed ID: 9595652
    [No Abstract]   [Full Text] [Related]  

  • 8. Significance of screening antibodies to hepatitis B virus core antigen among Syrian blood donors.
    Muselmani W; Habbal W; Monem F
    Transfus Med; 2013 Aug; 23(4):265-8. PubMed ID: 23621787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
    Katz L; Strong DM; Tegtmeier G; Stramer S
    Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Investigation of the presence of HBV-DNA in isolated anti-HBc positive cases and their importance in blood banking].
    Bal SH; Heper Y; Kumaş LT; Mistik R; Töre O
    Mikrobiyol Bul; 2009 Apr; 43(2):243-50. PubMed ID: 19621609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria.
    Jeremiah ZA; Idris H; Ajayi BB; Ezimah AC; Malah MB; Baba MM
    Hum Antibodies; 2011; 20(3-4):77-82. PubMed ID: 22129677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-HBc and post-transfusion hepatitis B. Problems pending solution].
    Acero D; Profitós J; Martí MJ; Palomer J; Caballería J; Bruguera M
    Med Clin (Barc); 1984 May; 82(20):910-1. PubMed ID: 6748797
    [No Abstract]   [Full Text] [Related]  

  • 13. American Red Cross experience with routine testing for hepatitis B core antibody.
    AuBuchon JP; Sandler SG; Fang CT; Dodd RY
    Transfusion; 1989; 29(3):230-2. PubMed ID: 2493695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks.
    Oluyinka OO; Tong HV; Bui Tien S; Fagbami AH; Adekanle O; Ojurongbe O; Bock CT; Kremsner PG; Velavan TP
    PLoS One; 2015; 10(7):e0131912. PubMed ID: 26148052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibodies to hepatitis B core antigen in blood donors and hepatitis non-A, non-B in blood recipients].
    Sugg U
    Beitr Infusionsther; 1988; 21():177-81. PubMed ID: 2462972
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-HBc screening of blood donors: a comparison of nine anti-HBc tests.
    Schmidt M; Nübling CM; Scheiblauer H; Chudy M; Walch LA; Seifried E; Roth WK; Hourfar MK
    Vox Sang; 2006 Oct; 91(3):237-43. PubMed ID: 16958836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticore antibody screening of transfused blood.
    Lander JJ; Gitnick GL; Gelb LH; Aach RD
    Vox Sang; 1978; 34(2):77-80. PubMed ID: 622820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
    Busch MP
    Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation of HBV-DNA using the polymerase chain reaction (PCR) in HBsAg-negative, anti-HBc-positive Venezuelan donors].
    León G; López JL; Maio A; García L; Quiroz AM
    Sangre (Barc); 1999 Oct; 44(5):342-6. PubMed ID: 10618910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.